Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy: A meta-analysis.

Wang, Wen-Lei; Aru, Na; Liu, Zhi; Shen, Xun; Ding, Yi-Ming; Wu, Shi-Ju; Qin, Huai-Hai; Jin, Wen-Yi

Wang, Wen-Lei; Aru, Na; Liu, Zhi; Shen, Xun; Ding, Yi-Ming; Wu, Shi-Ju; Qin, Huai-Hai; Jin, Wen-Yi.

Afiliação

Wang WL; Department of Neurosurgery, Emergency General Hospital, Beijing.
Aru N; Department of Hematology, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.
Liu Z; Department of Neurosurgery, Emergency General Hospital, Beijing.
Shen X; Department of Neurosurgery, Emergency General Hospital, Beijing.
Ding YM; Department of Neurosurgery, Emergency General Hospital, Beijing.
Wu SJ; Department of Neurosurgery, Emergency General Hospital, Beijing.
Qin HH; Department of Neurosurgery, Emergency General Hospital, Beijing.
Jin WY; Department of Neurosurgery, Emergency General Hospital, Beijing.

Medicine (Baltimore) ; 98(45): e17759, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31702627

Assuntos

Neoplasias Encefálicas/tratamento farmacológico; Glioblastoma/tratamento farmacológico; Temozolomida/uso terapêutico; Neoplasias Encefálicas/radioterapia; Quimiorradioterapia; Feminino; Glioblastoma/radioterapia; Humanos; Masculino; Terapia de Alvo Molecular; Prognóstico; Ensaios Clínicos Controlados Aleatórios como Assunto; Análise de Sobrevida; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Temozolomida Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google